Xarelto Cases Fast Approaching Court Date

More news on our continued coverage of the Xarelto mass tort cases:

June 11th is fast approaching, a significant day for members of the Xarelto federal multidistrict litigation. That day is when the attorneys for the plaintiffs get to present their scientific evidence to the court, and drive home their claims that they have linked bleeding complications to improperly disclosed Xarelto side effects.

Xarelto is a blood-thinning drug, one of the newest, and it is used to treat medical conditions such as deep vein thrombosis and atrial fibrillation. The characteristics of such a drug raise the possibility of bleeding, or hemorrhaging, which can be fatal. Warfarin, the predecessor of Xarelto, holds the same risk, but can easily be reversed with the administration of Vitamin K. The lack of a reversing agent, as well as understated yet potentially dangerous side effects, has led to over 300 MDL lawsuits. Their day in court is scheduled for June 11th.

I’ve Never Taken Xarelto, Should I be Worried?

Many drugs have side effects that may have been neglected in labelling or doctor education. If a pharmaceutical company does not attend to those issues, then they can be held accountable for the resulting injuries or deaths.  Colson Hicks Eidson has litigated several drug manufacturer cases over the past three decades.

If you or a loved one have taken or used a medical product and that you suspect led to a serious injury or death, talk to the personal injury lawyers at Colson Hicks Eidson. They can examine the case for free, and they represent clients nationwide.

UPDATE: New cases are still being added to the MDL against Xarelto and new evidence linking the drug to stomach bleeding, eye bleeding and pregnancy difficulties is being discovered. No word on how this will effect the case after the discovery session on June 11.

Colson Hicks Eidson—Injury Attorneys



Tags:

Leave a Reply

Your email address will not be published. Required fields are marked *